AI in Medicine News — 2026-11-11 (Wed) Daily News

Overview

Diagnostics and imaging had the most items, led by a study reporting AI-interpreted echocardiograms comparable to human reports (dicardiology.com). Hospital operations and clinical documentation also moved: AI scribe products were compared and health systems described how they decide where to use AI (CASRAI, Healthcare IT News, TechTarget). In drug discovery and regulation, funding and partnership news dominated, while one report said big pharma is tempering AI drug hype as investments surge without FDA wins (Chosunbiz).

Diagnostics and imaging

- A study reported that AI-interpreted echocardiograms were comparable to human reports, with cardiologists' time cut by about 50%. The headline does not give sample size, setting or study design (dicardiology.com). - A narrative review maps the limits of hybrid AI in mammography. This is a literature review, not a new performance measurement (Bioengineer.org). - An explainable machine learning model was reported to classify liver cancer accurately using routine clinical data. No figures or validation stage are given in the headline (Bioengineer.org). - An explainable AI model was reported to detect myocardial inflammation in cardiac MRI. No performance figures or validation stage are given (Bioengineer.org). - An article describes China as exploring a new pathway for medical AI that bridges R&D innovation and clinical adoption (TradingView).

Clinical decision support

- An interpretable machine learning model forecasts postoperative mortality in acute aortic dissection. The headline does not state accuracy or the stage of evidence (Bioengineer.org). - An article covers machine learning applied to EMS stroke triage. No results are given in the headline (HMP Global Learning Network). - Explainer pieces cover AI clinical decision support under FDA and ONC decision support intervention (DSI) rules, and the Infermedica and Kahun AI triage API and clinical decision support products (CASRAI). - A European patient survey found strong support for AI alongside concerns about empathy (Bioengineer.org). 【Generative AI and medical documentation】 - Product explainers cover the Twofold, Doximity and ScribeMatic AI scribes, including templates, HIPAA and EHR integration or API (CASRAI). - A comparison of Freed AI and Heidi Health scribes was published (CASRAI). - Sentara adapted clinical AI for case management (TechTarget). - None of the headlines report accuracy or safety measurements for these tools. 【Hospital operations and care delivery】 - Allina Health described how it decides where hospital AI can help (Healthcare IT News). - An article argues that evaluating ROI from AI is not always straightforward (Modern Healthcare). - An explainer covers AI governance in healthcare, including WHO principles and quality assurance (CASRAI). - Palantir lobbied a minister to consider extending its AI to GP records (Resultsense). - A Distilled Post article claims AI is taking over NHS hospitals and that hidden safety flaws will "shock you." The headline gives no evidence, and the claim is unverified. 【Drug discovery and clinical trials】 No headline states a development stage (preclinical, Phase I or later). - 3billion signed an AI drug discovery collaboration agreement with DeepLife (3billion). - Excelra's GOSTAR is reported to power Boltz's AI models for drug discovery (PR Newswire). - An article says AI is transforming bioprospecting for natural product drug discovery (Bioengineer.org). - Swiss VC Redalpine raised $250 million for AI, robotics and biotech (www.trendingtopics.eu). - PSC Biotech partnered with Clever Culture Systems on AI-enabled microbiology automation for pharma manufacturers. This concerns manufacturing, not a trial stage (EIN Presswire). 【Medical device approval and regulation】 No headline names a specific device clearance, designation or new guidance. - An explainer covers FDA artificial intelligence and AI/ML device rules (CASRAI). - Big pharma is tempering AI drug hype as investments surge without FDA wins (Chosunbiz). - Lunit will supply AI software to the Saudi National Guard health system. This is a supply arrangement, not a regulatory approval (AuntMinnie). - An explainer compares augmented and artificial intelligence in medicine (CASRAI).

Safety, errors and bias

No headline reports a specific error or bias finding. Items relate to governance and safety infrastructure: - Alterra Labs announced a $12.5 million seed round to build training environments for medical AI (Fortune). - Coalition for Health AI appointed three board members to advance responsible healthcare AI (citybiz). A separate explainer covers its model cards and HAIP (CASRAI). - Women's Health AI Consortium appointed three new board members from Midi Health, Women's Health, and the Center for Reproductive Rights (Morningstar). - Google tapped Clalit for a medical AI push, to be spotlighted at the Nas Daily summit in Jerusalem (Ynetnews). 【Research findings (major journals)】 No major-journal results appear in the material. - Five AI models were evaluated for irritable bowel syndrome patient information. The headline does not say which models or what the results were (Bioengineer.org). - Meituan released LongCat-2.5 AI model weights under an MIT License. This is not a medical result (Dataconomy). - Ioan Gruffudd warned of "distressing" scams using "explicit" AI content of him. This is not a medical result (London Evening Standard).

Developments in Japan

- Google Cloud announced Gemini for healthcare, described as agentic AI for medical use (Jetstream). - UiPath became a launch partner for Google Cloud's Gemini for Healthcare, bringing governed AI agents into clinical workflows (BigGo Finance). - Mainichi Shimbun's Kurashi Navi medical column asks whether creating knowledge with AI is difficult (Mainichi Shimbun). - TV Asahi News covered AI medical care in an era when average life expectancy exceeds 90, asking whether it could surpass doctors (TV Asahi News). - SORACOM is supporting vulnerability assessment through to countermeasure implementation for IoT and physical AI. The headline does not mention healthcare (Impress).

Statements from key figures

No notable developments.